kilitch-drugs-india-ltd
Home
Kilitch Drugs (India) Ltd
KILITCH Share Price
BSE:
NSE:KILITCH
KILITCH Share Price
BSE:
NSE:KILITCH
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹521.39 Cr
PE Ratio
31.66
Kilitch Drugs (India) Ltd Performance
▲
▲
▲
▲
Kilitch Drugs (India) Ltd Fundamentals
Kilitch Drugs (India) Ltd Delivery and Volume
About Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Limited (KDIL) was incorporated in May, 1992 as a public limited company. The Company is a pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and on
| Name | Designation |
|---|---|
| Mukund P Mehta | Chairman & Managing Director |
| Bhavin M Mehta | Whole-time Director |
| Hemang Engineer | Independent Director |
| Mira Bhavin Mehta | Managing Director |
| Murti Vasudev Krishna | Independent Director |
| Venkita Subramanian Rajan | Independent Director |
| Pushpa Nyoupane | Company Sec. & Compli. Officer |
| Dipen Jayantilal Jain | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Kilitch Drugs (India) Ltd FAQs
How do I Buy Kilitch Drugs (India) Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Kilitch Drugs (India) Ltd shares in BlinkX.
What is the Share Price of Kilitch Drugs (India) Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Kilitch Drugs (India) Ltd's share price is ₹325.9 as of 2024-12-13.
What is the PE ratio of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd's P/E ratio is 31.66 times as of 2024-12-13.
What is the PB ratio of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd's most recent financial reports indicate a price-to-book ratio of 2.75, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Kilitch Drugs (India) Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Kilitch Drugs (India) Ltd's market capitalization is ₹521.39 Cr as on 2024-12-13.
What is the ROE of Kilitch Drugs (India) Ltd?
The current financial records of Kilitch Drugs (India) Ltd show a 8.39% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Kilitch Drugs (India) Ltd?
According to Kilitch Drugs (India) Ltd's most recent financial filings, the company has a total asset value of ₹94.62, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Kilitch Drugs (India) Ltd?
The 52-week high/low price of a Kilitch Drugs (India) Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Kilitch Drugs (India) Ltd's 52-week high and low as of 2024-12-13 are ₹330 and ₹315.6, respectively.
